Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma In patients with advanced NSCLC, GCa ...
Lung cancer poses a potential smoke screen for today’s pulmonologists. Overall, incidence rates continue to decline in the US as other cancers are on the rise, yet a growing number of patients are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results